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INTRODUCTION 
 
 In  a high risk pregnancy, the birth of a healthy  child is a time of 
joy and expectation. The determinant of fetal growth and metabolism is 
the exchange between mother and fetus across the placenta. A well 
nourished new born therefore, is the best evidence of adequate placental 
functioning. The placenta acts as a major functional unit for the well 
being of the fetus.  
 Moosman defined placenta as a fusion of the fetal membranes to 
the uterine mucosa for the transfer of oxygen and metabolites between 
mother and fetal blood ( Williams 24th Edition). 
 As the placenta grows and ages, the histological changes suggest 
an increase in the efficiency  of transport to meet the metabolic 
requirements  of growing  fetus. Hence any insult to placenta during 
development stage quantification of the placental changes is essential to 
correlate the outcome in terms of the fetus. 
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 According to Benirshcke (1961)6 , the placenta is the most 
accurate record to infant’s prenatal experience and before the advent of 
ultrasonography,  its evaluation was possible only after delivery.    
 Ultrasound placentography was  first described by Gottesfeld 
(1966)15 while Grannum et al., (1979)16 proposed  grading system  for 
the  maturation of  placenta occurring with advancing gestational period 
With the advent of ultrasonography, antenatal evaluation of placenta has 
become essential in high risk pregnancy, as fetal problems and neonatal 
outcome depend upon the status, growth  and abnormalities of placenta. 
 The present work was undertaken to study the placental 
ultrasonography  in relation to histological changes occurring in high 
risk pregnancy and its correlation with fetal outcome. 
 Placental study may help in future pregnancy. Structural 
derangement may be the only way to study the fetal environment.  
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HISTORICAL ASPECT 
 Vesalius (1955) correctly, illustrated the human placenta. 
Realduscolumbus in 1559 first introduced the latin word ‘ Placenta’, 
Aristotle 384 – 322 BC first used the word ‘Chorion’, 
 Harvey  in 1651, set forth clearly the concept of fetal arterial and 
venous circulation in placenta. By the end of 17th century accurate 
concept regarding structure and functional significance  of  placenta and  
placental barrier was established.  
 In 1771, ‘Decidua’ was accurately described. In 1821, John and 
Lanter  descrinbed ‘ Decidual basalis’, In 1832, Webber  established the 
presence of ‘ Intervillous space’. In 1882, Langhans demonstrated that 
villi were covered by two layers of cells. In 1889, Habrecht introduced 
the terms ‘ Trophoblast’. 
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ULTRASONOGRAPHIC STUDY 
 Ultrasonographic placental grading  was described in 1966. 
Original, bistable technique with placenta appearing in outline as white 
speckled areas with boundaries in the uterine wall and amnio – chorionic 
plate. Early descriptions only provided positional relationship with 
uterus. With  the advent  of gray scale / real time technique,  variations in 
density, anatomy and positional relationships can be demonstrated. 
 Ultrasound evidence  of the developing placenta can be seen as 
early as 6 weeks of gestation. It appears as an area of high – level echoes 
surrounding a border representing the developing gestational sac. The 
echoes represent the chorion frondosom, which develops into definitive 
placenta. From 12 weeks of gestation the structures of the placenta can 
be more clearly  discrened. The 3 Structure are the  
a. chorionic plate 
b. substance of the placenta 
c. basal layer 
 Changes  in these structures represent the basis of placental 
grading.  Grading of placenta forms a par of fetal bio – physical profile.  
Grannum’s classification of placental grading. 
 
 
 5 
 
 
 
Region Grade 0 I II III 
Basal 
Layer  
No densities  No 
densities  
Linear 
arrangement of 
small 
echogenic 
areas  (basal 
stippling) 
Larger and 
partially 
confluent 
echogenic 
areas  
Placental 
substance  
Finely 
homogenous  
Few 
scattered 
echogenic 
areas  
Linear 
echogenic 
densities 
(comma like 
densities) 
Circular 
densities 
with central 
echo poor 
areas 
Chorionic 
plate  
Straight and 
well defined  
Subtle 
undulations  
Early 
demarcation of 
cotyledons in  
the direction of 
basal layer  
Septation of 
cotyledons 
extending to 
the basal 
layer  
 
The mean gestational age at which different  placental grades  appear  
and incidence of grade I placenta at term is shown in the following 
Table 
Mean Gestational 
Age in Weeks Placental Grade 
Incidence of grade I 
placenta at term ( %) 
31.3 I 40 
36 II 45 
38 III 5-15 
  
Modified Classification of Placental Grading by Kazzi 
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 The Standard  classification of placental grading, assigns  
placental grades  according to the most advanced portion of the placenta. 
For example if grade II changes are seen in one area, it is classified as 
grade II, irrespective of whether grade I or II exists. Hence,  Kazzi and 
associates (1955) examined placenta of 230 high risk patients  previously 
graded by Grannum’s technique  and proposed  a modified classification 
system.  
The mean gestational age at which different  placental grades  
appear  and incidence of grade I placenta at term is shown in the 
following 
Table 
Immature Intermediate Mature 
Diagnose only 
when not grade III 
areas were seen, 
i.e., grade 0.1 or II 
according to 
Grannum 
When only a portion was 
grade III, the remaining 
with grade I and II. 
Only grade III areas 
were present. 
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Clinical Significance of Placental  Grading ; 
1.  In post term pregnancy ( >42 weeks) grade 0 or I does not exist.  
Only grade II or III configuration is found. With grade III Placenta 
abnormal fetal heart rate patterns have been noted. 
 
2. I cases  of Intra uterine  growth retardation and Pregnancy induced 
hypertension, there is  accelerated placental maturation. i.e. grade in 
< 27 weeks, grad II in <32 weeks and grade III in < 34 weeks.  
 
3. Delayed maturation is associated with gestational diabetes. i.e, grade I 
in > 30 – 32 weeks.  
 
PLACENTAL THICKNESS 
 The  thickness of placenta  is measured between cord insertion and 
lateral edge of the placenta. The following table shows the mean 
placental thickness  associated with different   placental grades.  
  
mean thickness of 
placenta ( cm) grades of placenta 
3.8 I 
3.6 II 
3.4 III 
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Clinical significance of placental thickness 
1. Thickness of < 2.5 cm is associated with poor intrauterine 
environment (IUGR). 
2. Thickness of > 4 cm is an early sign of fetal hydrops (upto  8 cm) 
diabetes mellitus and maternal syphilis.  
In conclusion,  acceleration of placental maturation and 
ultrasonographic grading leads to two to eight fold increase in fetal 
morbidity.  
 
DEVELOPMENTAL STAGES OF PLACENTA 
 The  human placenta is of haemochorioendothelial type.  
Late day 6 to early day 8 post conception : Prelacunar stage of 
trophoblast : The  blastocyst is partially implanted.  
Late day 8 to day 9 : Early lacunar of Trabecular stage : The  
syncitiotrophoblast at implantation pole exhibits vacuoles – forerunners 
of the lacunar system.  
Day 10 to day 12 : Late lacunar or trabecular stage :  Implantation 
is complete.  The  syncitiotrophoblastic vacuoles fuse to form the lacunar 
system.  First contact of lacunar system with eroded endometrial 
capillaries is the first sign of decidualization.  
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Day 13 : Early Primary villous stage ( first free primary villi) : The  
syncitiotrophoblast forms the trophoblastic  trabecular forerunners of 
stem villi. Trophoblastic out growth  into the lacunae from the villous 
stem.  
Day 15  to Day  16 : Early secondary villous stage : From 
implantation to anti implantation pole, the extra embroyonic 
mesenchyme from the chorionic cavity  invades the villi forming the 
secondary villi. 
Day 9 to Day 21 : Early tertiary villous stage  : In villus, fetal 
capillaries develop.  
Day 23 to Day 26 : Villous trophoblastic surface composed of outer 
syncitio and complete inner cytotrophoblast. Chorionic plate consists of 
fetal mesenchyme, cytotrophoblast and syncitio trophoblast. Intense 
mixing of decidual and trophoblastic cells from the basal plate.  Tissue 
necrosis in the contact zone form the Nitabuch fibrinoid.  
Day 29 to Day 49  :   Mesenchymal villi show increased number of 
macrophages and stromal channels.  Medium sized villi show reticular 
stroma of immature intermediate villi, Peripheral portions of villi in 
primary stage increase in size and ten undergo fibrinoid degeneration.  
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Day 43 to 70 (third month)  :  Around anti – implantation pole,  the 
fibrinoid deposition initiate the formation of chorion laeve.  
Fourth month : Continuous degeneration of villi at anti – 
implantation  pole and proliferation of villi at implantation pole initiate 
the differentiation of chorionic sac into chorion and placenta.  
 The fetal vessels show concentric  adventitial fibrosis to such  an 
extent that about half of the arterial and venous adventitia fuse forming 
central villous core – first real stem villi.  
Fifth Month : Stem villi increase in number.  
Sixth Month ; Immature intermediate  villi are transformed into stem 
villi and the large villi are  completely fibrosed.  
Seventh Month : In locally restricted areas,  obviously in the periphery of 
villous trees,  small group of grape – like, highly capillarized terminal 
villi develop. Cell columns surrounded by fibrinoid deeply invaginate 
into the basal plate.  Syncitiotrophoblast covering the chorionic plate is 
replaced by a thin layer of fibrinoid which grows in thickness forming 
Langhan’s stria.  
Ninth Month : Large parts of syncitiotrophoblast of stem villi are 
replaced by fibrinoid. Superficial stroma shows increased number of 
fibroblasts. Central  stem villi are highly fibrous. Majority of villi are 
intermediate and terminal villi.   
 11 
 
Tenth Month : Mean placental weight increases from 400 to 470 grams. 
Increased number of terminal villi ( 40 % of total villous volume of the 
placenta). 30 to 40 % villous volume consists of intermediate villi. The 
amount of previllous  fibrinoid is extremely variable.   
 
GENERAL PATHOLOGY OF PLACENTA 
MACROSCOPIC ABNORMALITIES OF PLACENTA 
1.  Development Abnormalities  
a.  Placental extrachorialis: Commonest development  abnormality 30 % 
- H. Fox 2007)10. The Chorionic plate from which the villi arise is 
smaller than the basal plate and hence the transition from villous to 
membranous chorion takes place not at the edge but at same distance 
within the circumference of te fetal surface, thus leaving a ridge of 
villous tissue projecting beyoudn the chorionic plate.  
b. Placenta Membranacea : All or most of the  membranes are covered 
on their outer aspect by placental villi. Incidence  - I in 20000 to I in 
40000. 
c.  Accessory lobe ; Adjacent to the main placenta there may be found 
one or more accessory lobes of variable size. Incidence – 30 %. 
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d.  Bilobate  placenta : This consists of two approximately equal  lobes  
which may be  connected by a bridge of chorionic tissue or may be 
quite discrete from each other. Incidence – I in 350 (Earn 1951). 
e.  Fenestrate placenta : This a condition in which the central portion of a 
discoidal placenta is missing.  
f.  Ring  shaped placenta : Also known as ‘ gride or annular placenta’ 
The placenta is annular in shape and resembles a segment of a hollow 
cylinder.  
 
2. Lesions Reducing Mass of Functioning villi : 
a. Previllous fibrin deposition : Some degree of fibrin deposition around 
villi occurs  in almost in all placentae,  but in a proportion is sufficiently  
extensive to be macroscopically visible  either as a firm  white plaque or 
as area of irregular,  whitish  mottling. There is a low incidence of these 
plaques in placentae from eclamptic women and very low incidence of 
fetal hypoxic complication associated with the presence of this lesion ( 
Fox 2007). 
 
b. Infarction : A fresh placental infarct is well demarcated, dark red and 
moderately firm. Older lesions are hard, yellow white plaques.  Small 
areas of infarction involving < 5%  of villous parenchyma, are common 
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occurring in 25% of placenta from uncomplicated pregnancy and are of 
no clinical significance. > 10 % is associated with a high incidence of 
fetal hypoxia, growth retardation and Intra uterine Death ( Kloosterman 
and Heridekoper  1954;  Little 1960 ; Fox 1976 ; Naeye  (1977)30. 
Infarction occurs against a background of a markedly abnormal maternal 
vasculature and restricted blood flow to placenta as a result of inadequate 
transformation of spiral  arterioles into  utero – placental vessels 
(Robertson et al., 1975 ; Robertson 1976, 1981). 
c.  Fetal artery thrombosis ; Seen macroscopically as a rough triangular 
area of pallor within the placental substance. Histologically, te stroma of 
these villi becomes  fibrotic  and fetal vessels undergo an obliterative 
sclerosis.  Found in 4%  of placentae from live births.  Seen in fetus of 
mothers with hyper coagulable  status in association with anticardiolipin 
antibodies and protein S deficiency (Kraus 1993 and Rayne and Kraus 
1993). 
d.  Primary defect in placental growth :  Physiological capacity of the 
placenta  is related to its weight  and the functional  deficiencies of a 
small placenta well restrict fetal growth. Placental : fetal weight ratio has 
been considered to be of significance ( Little 1961, Thomson et al 1969 ; 
Lemtis and Hadrich 1974, Motteir et al 1978). Placenta has a potential 
for further  incremental growth, indicated by unduly large placenta as 
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found in pregnancies in high altitude,  severe  maternal anaemia and 
maternal heart failure (Clavero – Nunez 1963; Beischer et al 1970, 
Kruger and Arias Stella 1970 ; Agboola 1975; Godfrey et al 1991).  
e.  Haematomas and Thrombi  
-  Retroplacental  haematoma : This haematoma lies between,  and 
seperates the basal plate of the placenta and the uterine wall. They  are 
found in 5% of all placentas though it is increased three fold in those 
from pre – eclamptic women (Fox 1978). 
- Subamniotic  haematoma : This occurs  on the fetal surface of the 
placenta as a plum coloured  tumefaction which lifts the amnion from 
the chorion,  results from tearing of surface chorionic veins by 
excessive cord traction. Old haematomas tend to be associated with a 
low birth weight ( Deans 1998). 
-  Marginal  Heamatoma :  This is crescentric  lesion  at one edge of the    
placenta. This type occurs  in placenta which is implanted  in the 
lower uterine segment, i.e., a lateral placenta praevia ( Wilkin 1965). 
-  Intervillous  thrombi : Lies approximately  mid way between fetal and 
maternal surfaces.  Measures 1 to 2 cm and are known as ‘ Kline’s 
haemorrhages. Found in 40 % of all placentas ( Fox 1978).  They can 
cause elevated  maternal  alpha fetoprotein ;levels ( saffix 1988).  
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f. Calcification : Calcification is considered as an evidence of placental 
senescence or degeneration. The cause of calcification is unknown.  
Occurs  most commonly  in first pregnancies,  low maternal age, high 
maternal socio – economic  status and delivery  during summer months 
increasing material serum calcium levels ( Fox 2007).  
 
HISTOLOGICAL ABNORMALITIES OF PLACENTA 
a . Abnormalities of villous maturation and differentiation ( Villous 
maturity) : A deficiency of terminal villi towards the end of 
gestation  ( Villous immaturity) is associated  with high incidence  
of  fetal            growth  retardation ( Becker 1975, 1981).  
b.  Changes  secondary to reduced  maternal blood flow 
(Cytotrophoblastic  proliferation) : There is an undue  prominence 
and number of  villous  cytotrophoblastic cells together with 
irregular thickening of the  trophoblastic  basement membrane,  
which is probably an incidental by –  product of  cytotrophoblastic 
cell hyperplasia. Hence,  the response of placenta to  ischaemia is a 
reparative one.  
c.  Changes secondary to reduced  fetal blood flow ( Syncitial knots 
and Fibrosis ) : These are seen in a group  of villi, which while fully 
`oxygenated from maternal blood, have been deprived of their fetal  
 16 
 
circulation by thrombosis of a fetal stem artery.  such villi  show 
stromal fibrosis and  excess syncitial knots as seen in cases  of 
prolonged pregnancies.  their  appearance in placenta as gestation 
progresses is a  time  related phenomenon, but is not a true aging 
change.  
d.  Abnormalities  of unknown pathogenesis : 
 - Fibrinoid Necrosis :  Appears as a small nodule of 
homogeneous,  acidophilic, PAS – Positive material  at one point in the 
villous trophoblast.  Enlarges as fresh fibrinoid material to form a mass,  
attributed to immunological reaction within villous tissues.  
 - Villous edema :  Its presence  is correlate with increased  
water  content of placenta ( Barker et al 1994). It has been suggested that 
the  increased size of placental villi decreases the capacity of the 
intervillous space and hence restricts  maternal blood flow to the  
 placenta. ( Alvarez et al. 1972  ; kovalouszki et al. 1990).   
 Naeye et al.  ( 1983) also considered villous edema to be  
indicative  of fetal hypoxia.  
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ANATOMY OF THE UMBILICAL CORD  
 Consists  of 2 arteries and one vein,  surrounded  by Wharton’s  
jelly which, in turn, is  coated by  one or more layers of amniotic 
epithelium. Wharton’s jelly is made of mucous or myxoid tissue,  
composed of scanty,   large, stellate cells,  giving rise to collagenous 
fibres,  which increase in number with gestational age and are 
concentrically arranged  around the blood vessels.   
The ‘valves’ of Hoboken are a peculiar feature of the  umbilitcal 
cord arteries – Constructions of the lumen,  occurring  at varying  
intervals.  Schare   (1986) considers these as a transient phenomenon. 
 
ABNORMALITIES OF UMBILICAL CORD  
Length of the cord  
  The minimal length  of the cord allowing  normal vertex  delivery 
at term  has been calculated  to be 32 cm. A too – short cord may lead  to 
obstetric problems  like mal presentation, abruptio placenta,  
intrafunicular  haemorrhage and inversion of the uterus. Too long a cord,  
is likely to facilitate entanglement,  prolapsed of the cord and 
thrombosis.  
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Placental Insertion of the Cord 
 The  relation of the  attachment of  the Umbilical  cord to the 
surface  of the  placenta is determined by the position of the inner cell 
mass in relation  to the uterine wall.  Marginal  insertion gives rise to so 
called Battledore placenta.  When  the cord is implanted on the  
membrane  away  from the  margin of the placenta  it is called 
velamentous insertion.  
Knots of the Cord 
  According  to Spellacy and co – workers,  the incidence of true – 
knotting is 1.1 % and is  associated with 6.1 % of perinatal mortality.  
Absent  Umbilical artery  
 It is noted in about 1 % According to Benirschke,    20 to 40  % of 
all infants  with one umbilical  artery  have associated Congential 
anomalies. The birth  weight is likely to be lower  than the normal.  
Supernummary Umbilical Vessels 
 The possibility  that accessory vessels found  in the umbilical cord 
may be partial remnants  of an incompletely regressed umbilical vein 
(Meyer et al ; 1969). Gupta et al  ( 1993) found  a positive correlation 
with inflammatory cell infiltration  of the cord and a highly significant 
association with maternal smoking.  
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PATHOLOGY OF MEMBRANES  
Amnion   
 Reflects  the condition   of infant’s skin as it is continuous with the 
surface of the umbilical cord Therefore, reflects the epithelial disorders  
the infant and can itself  respond to injury with inflammation.  
 
Colour of the membrane  
 Opaque  membrane  is associated with acute or chronic infection. 
Meconium   passage is uncommon prior to 38  weeks and increase  after 
40 weeks  and is associated with increased  perinatal morbidity and 
mortality. Meconium staining of the umbilical  cord and membranes  has 
recently been claimed to induce necrosis of umbilical vessels and cord 
(Altscyler et al, 1992 ; Bernischke, 1994)2,6.  
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AIMS AND OBJECTIVES 
 
1. To  find out placental  maturational  changes (Grading and 
Thickness) ultrasonographically in high risk pregnancy.  
 
2. To find out the histopathological changes of placenta in high risk 
pregnancies  including  pregnancy induced  hypertension,  post 
term  pregnancy, Diabetes mellitus  complicating pregnancy,  
preterm  pregnancy  and pregnancy  complicated by antepartum 
haemorrhage.  
 
3. To correlate above findings with fetal  outcome  (fetal distress, 
mode of delivery,  birth weight, Apgar at 5 minutes, still births 
and perinatal deaths).  
 
4. To compare  the results  of normal and high risk pregnancy 
groups.  
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REVIEW OF LITERATURE 
 
All placenta should be examined grossly. This can be performed 
by the healthcare providers present at the time of birth and can be   done 
with a basic knowledge of placental anatomy, and an understanding of 
the abnormalities and variations that affect the placenta. 
 Pathological findings in the placenta may be useful in 
understanding adverse outcome in one of two ways. Firstly, the placenta 
per se can be abnormal and thus contribute to the adverse outcome. 
Secondly, the placenta may harbor abnormalities that  may point towards 
the presence of an adverse intrauterine environment.  
 Examination of the placenta performed in the labour room 
provides information that may be important to the care of both mother 
and infant. 
During the examination, the size, shape, consistency and 
completeness of the placenta, the presence of accessory lobes, placental 
infarcts, hemorrhagic areas, tumours and nodules should be noted. The 
umbilical cord should also be assessed for length, insertion, number of 
vessels, knots and the presence of Wharton’s jelly. 
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 The color, luster and odor of the fetal membranes should be noted. 
Tissue may be retained because of accessory lobe of the placenta or 
because of placenta accrete, placenta increta or placenta percreta. 
 Numerous common and uncommon findings of the placenta, 
umbilical cord and membranes are related with abnormal fetal 
development and perinatal morbidity. The placenta should be sent for 
pathologic evaluation if an abnormality is detected. 
 Examination of the placenta can yield information that can help in 
the immediate and later management of mother and infant. This 
information may also be essential for protecting the attending physician 
in the event of an adverse maternal or fetal outcome. 
 Although some experts say that all placenta should be examined 
by a pathologist, most hospitals do not mandate this examination. 
Instead, the delivering doctor is usually responsible for determining 
when pathologic analysis is necessary. The examination of normal 
placenta and most abnormal placentas can be done within one minute. 
Universal assessment of the placenta in the labour room, with 
documentation of findings and submission for pathologic evaluation 
based on abnormal findings or certain clinical indications, is standard 
medical practice. 
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Boyd and Hamilton ( 1970)  William 24 edition. 97 : The  placenta 
at term is. on average, 185 mm in diameter and 23 mm in thickness, with 
an average,  volume of 397 ml and weight  of 508 g ; but these 
measurement s vary  widely. There are multiple shapes and forms fo the 
human placenta and a variety  of types of umbilical cord insertions.  
Wiswell and associates (1990)  Williams 24 edition,  ; Incidence 
of meconium  staining  in 12 % of 1,75,000 live born infants.   
Benirschke and Kaufmann ( 2000) Williams  24 edition, :  
Identified  visible  meconium staining in 18 %  of 13, 000 consecutive 
placentas.  
Morrisan JE, ‘ Fetal & Neonatal Pathology’ , 2nd Edn. 
Butterworths  : :London, 1963. At term the placental – fetal ratio lies 
between 1 : 6 to 1 : 829.  
Hansen A, Collins  MH,  Genset  D, et al. Pediatr Dev Pathol 2000  
Sep – Oct ; 3 (5 ) 419  -30 (ISSN : 1093 – 5266) : Examination of the 
VLW  Infant’s  placenta provides insight into the etiology and 
management of VLBW  and preterm  deliveries20.  
Naeye RL Human Pathology 18 : 387 -  392, - 1987. This study 
attempted  to determine  if placental size has implications  of fetal and 
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neonatal health and  subsequent  childhood growth  and development.  
38,351 placentas were trimmed and weighed in a standardized way.  
Over weight placentas,  largely a result of villous edema, were associated 
with following  neonatal evidences  of acute neonatal  hypoxia. Low 
Apgar scores, respiratory distress syndrome, neurologic  abnormalities 
and neonatal death. Neurologic abnormalities were  33 % more frequent 
when placentas  had been overweight than they had been normal 
weight30.  
Anjali RM, Leela RK and Prabhatkumar SP FOGSI J. 2 : 294 – 
300, April 1985. Subject – 100 high risk cases. The counts of syncitial 
knots were found to range between  0-39 %  in normal control group 
while  between   30 – 59 % in all other groups.  Cases  of fetal distress 
(46. 8 %)  and still births  ( 62.  5%) in   were showing syncitial knot  
count  of grade II and  grade III  respectively. Leucocytic infiltration of 
umbilical cord was found in 2.3 % of toxaemia and 4 %  of normal 
group. No correlation with fetal hypoxia  was noted.  Villi  showing  
fibrinoid necrosis of more than  5 % were found in cases of toxaemia 
(59.5% )  and diabetes ( 60 %) . The count was between  0-5 %  in all 
uncomplicated  cases and  in most cost with IUGR  ( 70 %).  Incidence 
of fetal  distress was found to be more in toxaemia ( 40. 4%) Low Apgar 
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score  was  observed more in toxaemia ( 38.  09%) and intrauterine 
growth retardation  ( 30 %) cases.  Percentage of still birth in toxaemia 
was 11.9 % and in diabetes 20 % with placentas weighing less than 300 
gms, fetal distress  ( 43.3%) and  low APGAR scores ( 43.3 %)  were 
observed3. 
Marianne S,  Chakrawarthi  RN, and Devi PK : Journal of  
Obstetric  Gynaecology. India,  26 : 216 – 21, 1976, 53 high risk 
subjects. Counts of  syncitial knots  were found to range  between  30 – 
50 % in majority of normal  cases. Malkani, Bhasin PK and Bhasia : J. 
Obstetrics.  Gynaecology. India, 18 : 666, 1968. Suggested and excess  
of over 30 %  count to be indicative of excessive aging due either to post 
– maturity or a disease  stage causing  placental  insufficiency. About 93 
% of the normal  cases  showed < 7% stromal fibrosis ( > 10%). The  Rh 
incompatibility group showed  moderate fibrosis –    (6 – 10%) in  28% 
of the placentas,  although  almost 71 %  had mild fibrosis     ( 6%) . In 
the  post mature group, stromal  fibrosis  of > 10 % was observed  in 25 
%  of the cases.  In the normal group  only 16.6 % showed fibrinoid  
necrosis  of < 3 % 42 % of Rh incompatible group and 34 % of toxaemic 
group showed > 6 % fibrinoid material28.  
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Neerja, Bal Manjit S and Chandra P : Journal  of Obs.  Gynae.  
India,  5 : 603 -  607, October  1999,  Normal Subjects – 50 and  high 
risk subjects 50. Placental weight in study group was found to be less 
than 300 gm in 22 % of  cases, 300 to 400 gm in 50 % and > 400 gm was 
found  in 28 %  of cases.  None of the patient  in control group had 
placental weight less than 300 gms.  instead  all cases had more than 400 
gms.  Syncitial knot formation in > 30 % of villi was found in 66 %  of 
patients  in study group,  while only 6 % of control group. 12%  had 0.3 
to  3 % stromal fibrosis and 32 % in study group had > 3% stromal  
fibrosis of villi. 1.5 % of fibrinoid necrosis was observed  in 36 % of of 
study group, 5 to 10 %   in 40 % and > 10 %  in 24% of cases. 
Leucocytic infiltration  was observed  in 30 %  of cases  of study group 
compared to none  in normal group. Fetal distress was observed  in 34 %  
of cases of study group as compared  to 12 % in control group32. 
Karla VB,  Aggarwal A and Sareen PM : FOGSI J. Obstet.  
Gynec. India,  35 : 7 to 11, 1985. Histopathological changes in placenta 
in toxaemia in pregnancy. Syncitial knot counts per 100 vili were found 
to be  significantly increased  in cases of severe  pre – eclampsia.  There 
was increased  incidence  if stromal fibrosis and  fibrinoid necrosis in 
toxaemia cases23.   
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Godbole     PV, Mehendale  SS and Vasanti Le Le : J.  Obset. 
Gynee. India, 138 : 406 to 409, 1988.  100 High Risk subjects.  On Gross  
examination of the placenta  from cases of IUGR 35 %  showed 
calcification. 41 %  showed  infarction and 27 %  showed  fibrin 
deposition. 70.2%  showed  presence of  leucocytic infiltration and 
syncitial knots were present in 88 % of placentas14.  
Bandana,  D. Dutta D, Chakraborty S, and  Nath P  : FOGSI 
Journal of Obstet.  Gynaec. Ind. 46 : 40 to 46, Feb. 1996. 20 normal 
subjects  and 80 hypertensive  subjects.  Weight of 25 placentas were 
below 300 gms at term,  whereas  none of the  placenta was below  300 
gms in normotensive  control group. The shape  of placenta  was normal 
in 85 %  of normotensive and 65 %  of hypertensive  cases.  The 
insertion of the cord was central  in 80 % cases of control group  and 
56.25 % in hypertensive group. The incidence of placental  infarction 
involving > 5% of parenchyma in hyoertensive disorders ( 50 %) and its 
was absent in 75 % of normal cases and when present,  it involved  < 5 
% of the total surface area5.  
Avasthi K, Midha  U, Sabharwal, B.D. and Kirna Devi : J.  Obset . 
Gynaec. India, 41 : 317 to 23, 1991. 125 placentas  from abnormal and 
100 from normal subjects.  48 % showing syncitial knots in 30. 59 %  of 
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villi and 80 % cases syncitial  knot formation in 60 . 89 % of villi had 
fetal distress. Incidence of still birth was 22.44 %  in group  showing 
syncitial   knots 30. 59 % of villi and 40 % in group with syncitial knot 
in 60. 89 % of Villi. The incidence of fetal distress was highest in post – 
maturity ( 60%)  and Rh incompatibility ( 60 %)  group followed by 
toxaemia ( 35 %)  Low APGAR  scores were more frequently  observed  
in cases  with toxaemia  ( 25 %)  percentage of still births  were highest  
in Rh incompatibility group ( 20 %) followed by toxaemia ( 12.5 %)4.  
Wolf H, Dosting H and Jreffers PE : Am J.  Obstet. Gynaecol. 16 : 
121- 129, 1989. has given  evidence that fetal growth retardation is 
preceded by reduced  placental volume growth52.  
Gerisson RT, Oystow SA and Patel NG : Br J. Obst. Gynaec. 92 : 
46 – 53, 1985. Found the growth rate of placental volume reduces after 
30wks and even falls towards term13.  
Yin L, Liu Y, Ma H Tianjin Medical University, Second Hospital : 
Chung Hua Fu Chan Ko Tsa Chin 1998 July ; 33 ( 7) : 415 – 8. After 
term pregnancy the placental  function is gradually lowered especially in 
prolonged pregnancy.  The situation of the placenta, amniotic fluid and 
fetus should be monitored after 40 gestational weeks53.  
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Jauniaux E, Moscoco G, Champbell S, Gibb O, Driver M and 
Nicoladides KH : Correlation of ultrasound and pathologic findings of 
placenta.  Euro Journal of Obset.  Gynec. Reprod. Biol 1990. Concluded 
that placental thickness is not diagnostic of any particular condition but 
can contribute to the management of fetus  at risk. Thick placenta of  >  
4 cm can be an early sign of developing fetal hydrops  of various causes 
as in uncontrolled maternal diabetes22. 
Petrucha RA and Lawrence D : Am  J. Obset. Gynec. 144 : 733 to 
735, 1982. The study suggest that placental grade is a function of 
gestational age and no conclusion  can be reached concerning the 
relation of these grade III placentas to pulmonary maturity35.  
Kazzi GM, Thomas LG, Mortimer GR et al :  Am. J. Obset. 
Gyneac. 148  : 54 – 58, 1984. In their prospective study of 230 term and 
preterm complicated subjects studied the relationship  between placental 
grading, fetal lung maturity and neonatal outcome in normal and 
complicated pregnancies, suggested that t presence of grade III placenta 
is affected by  both gestational age and pregnancy complications  and 
that a grade III placenta in a reliable indicator of fetal lung maturity.    
Kazzi GM, Thomas LG, Robbert JS and Nadya Jk : Am J. Obset 
& Gyne. 1145 : 733 – 737, 1986. 224 subject examined sonographically 
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within 7 days  of delivery.  The presence of a grade III Placenta followed 
by the delivery  of a SGA infant in 59 % of cases and that  62 % of SGA 
infants can be correctly identified.  
Harman  CR, Manning FA, Stearns E and Marisson : Am J. Obset. 
Gynae. 143 : 941 – 43, 1982. The correlation of ultrasonic placental 
grading and fetal pulmonary  maturation in 573 pregnancies found that 
grade III plancenta was associated with immature L / S ratio in 8 to 42 % 
of cases21.  
Roy B : J. Obset. Gynaec. 44 : 343 to 48, 1994. Clinical 
Significance  of placental grading by sonor. 50 normal and 115 high risk 
subjects. In normal cases placental grading had a definite correlation 
with gestational age, being higher with advancing  pregnancy. In high 
risk group, placental  maturity was accelerated, being higher than normal 
pregnancy of similar gestational age. Cases of diabetes and Rh 
incompatibility ( 16 % ) however.  showed delayed  ( 100%) placental 
maturity and lower grades were found even in cases approaching term. 
Placental maturity showed a direct correlation with pulmonary maturity. 
RDS never developed  when placenta had shown grade II or III 
maturity41.  
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Quinlan RW, Amelia CC : Am J. Obset.  Gynae. 142 ; 110 – 111 
1982, The association of preterm appearance of grade III changes in the 
placenta in complicated  pregnancies suggest that the changes are 
associated with premature  senescence of placenta.  A high incidence   
(78 %) of prenatal problems were found in association with grade III 
placenta38.  
 Quinlan RW,  Amelia CC, William C, Bahi and Magdeline MR : 
AM J. Obset. Gynae. 144 : 471 – 473, 1981. In the 1 Year period of time 
between January 1, 1981 and December 31, 1981, 1936 obstetric  
ultrasound, the grade  III placental changes  occur  with increased 
frequency in post mature pregnancies.  78 % of pregnancies with preterm 
grade III changes were associated with significant perinatal problems  
like : hypertensive complications  of pregnancy, IUGR, fetal distress and 
intrapartum bleeding.  
Gasst MJ and William Ott : AM J. Obstet. Gynaec. 146 : 464 to 
465, 1983. Reports suggested that there is a 100% correlation between 
neonatal  lung maturity, mature amniotic  fluid,  concentration of 
surfactant  and the appearance of a grade III placenta12.  
Grannum P, Berkowitz RL and John HC : Am J. Obset. Gynaec. 
133 : 915 to 922, 1973. 129 subjects  Mature L / S ratio ( 2.0) were 
found  in 68 % of Grade. 1, 88 % of Grade II and 100 % of Grade III 
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Placentas. These results suggest correlation between  maturational  
changes of the placenta as seen by ultrasound and fetal pulmonic 
maturity as indicated by L/s ratio.  
Veena A and Sapna J : Placental grading by ultrasonography : J. 
Obstet. Gynaec. India , 50 : 59 – 62, 2000. 125 normal and 125 high risk  
pregnancy  cases after 28 wks.  Placental  grading advanced with the 
gestational age in both low risk and high risk groups, but found to be  
accelerated in cases of IUGR  and hypertension,  with a delay in 
maturation  in cases of Rh incompatibility and diabetes  mellitus.  There 
is no definite relationship  between  low birth  weight and low APGAR 
scores, but there  was a direct correlation with pulmonary maturity. 
There was no development of RDS when placenta was grade III45. 
Tewari K, Tyagi SP, Saxena K, Usmanai F and Begum R : 
ultrasonographic and histological study of placenta in abnormal 
pregnancy  cases  J. Obstet Gynaec. India, 47 ; 199 – 26, 1977. 49 high  
risk subjects. The mean gestational age for  appearance of placental 
grade I, II and III  was significantly earlier in cases of IUGR,  while it  
was only  significantly earlier in grade I and II in toxaemia.  70%  of 
cases with preeclampsia  had grade III  changes prior to  delivery as  
compared to 40 %  of normal case. In cases of prolonged pregnancy, 
gestational  age for appearance  of different  placental grades was similar  
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to that of  normal pregnancy,  while 100 %   of cases with diabetes  
showed delay in appearance  of grade I changes  only and none had 
grade III changes  even at 38 weeks.  In Rh incompatibility, appearance 
of different grade  changes ( 50 %) were almost  similar to normal 
pregnancy. There is an increase  in syncitial knot count , fibrinoid 
necrosis and fibrosis in grade II  Placenta of pre – eclampsia and 
prolonged pregnancy as compared to grade II  and grade III normal 
placenta43.  
Tewari K, Tyagi SP, Saxena K, Usmani F and Begum R : J.  
Obstet. Gynaec.  45 : 440 – 44, August , 1995. 20 normal subjects.  The 
mean placental thickness was found to be maximum  between 28 to 32 
wks of gestation and a progressive decrease was noted till term. 
 Mean gestational age    Grade 
 31.2 + 1.92 wks     I 
 35.6 + 1.6 wks     II 
 37.5 + 1.2 wks     III 
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Grade        Mean placental thickness 
             (Single + serial scan) 
 
 I      49. 7 + 5 .4mm 
 II      40 + 3.4 mm 
 III      34.2 + 3. 6 mm 
 
 Fibrinoid  necrosis,  vasculo – syncitial membrane  changes and 
stromal fibrosis were increased significantly in grade III as compared to 
grade II placenta, while syncitial knot count increased insignificantly.  
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MATERIALS AND METHODS 
 
1. Stratified random selection of 50 cases of high risk pregnancy                       
[ Hypertension – 10  , preterm labour – 10 cases, diabetes 
mellitus – 10 , antepartum haemorrhage – 10 and post term 
pregnancy – 10 and 50 cases of normal pregnancy of gestational 
age more than 28 weeks, from RMH, THANJAVUR MEDICAL 
COLLEGE, THANJAVUR. (from june 2016 to july 2017). 
2. Ultrasonographic placental study  was done [ grading according 
to Grannum’s grading system ( 1979) and thickness  measured 
from site of cord insertion to the margin of the placenta ], with in 
one week prior to delivery. 
3. Placentas from high risk and normal  pregnancies were collected 
and fixed with 1 % formalin. Placental cross sectioning was 
done through the  entire  thickness  beginning  from one to the 
other margin at 3 to 4 cms distance. 3 bits,  one from normal and 
two from abnormal areas were  taken for histopathological 
examination.  
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4.  Macroscopic  study of placenta included the following  : 
 -  shape  of the placenta 
 - weight in grams  
 - size, diameter in centimetres 
Examination of the  umbilical cord : 
- cord length  in centimetres 
- number of cord vessels 
-  anomaly of the cord 
5.  Macroscopic  study of placenta included the following  : 
Syncitial knots ( graded according to the percentage  of area 
involved)  
Fibrosis ( graded according to the percentage of area involved)  
Fibrinoid necrosis  ( graded according to the percentage  of area  
involved) 
Leucocytic infiltration 
Infarction ( in percentage  of area involved) 
Calcification  ( in percentage of area involved) 
6.  For Fetal outcome the following parameters were studied : 
- Fetal distress 
- Mode of delivery 
- Birth weight ( gms) 
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- Apgar score at 5 minutes 
- Still births 
- Perinatal deaths 
 
INCLUSION AND EXCLUSION CRITERIAS: 
 EXCLUSION CRITERIA: 
• G.A < 28 weeks. 
 INCLUSION CRITERIA: 
• Hypertension. 
• Preterm labour. 
• Diabetes mellitus. 
• Antepartum Hemorrhage. 
• Post term pregnancy. 
• Normal pregnancy of G.A > 28 weeks. 
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Table 1: Distribution of complications in the high risk group of the 
study. 
 
Data are expressed as absolute number with percentage 
 
 
 
S. 
No 
High risk 
factor 
Primi 
gravida 
(n=25) 
Percentage 
(%) 
Multi 
gravida 
(n=25) 
Percentage 
(%) 
Total 
(n=50) 
Percentage 
(%) 
1 Antepartum Hemorrhage 5 20 5 20 10 20 
2 
Gestational 
Diabetes 
mellitus 
4 16 6 24 10 20 
3 Gestational Hypertension 6 24 4 16 10 20 
4 Post dated 4 16 6 24 10 20 
5 Preterm 6 24 4 16 10 20 
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Figure 1: Distribution of the complications amongst primi 
gravida in the high risk group of the study. 
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Figure 2: Distribution of the complications amongst multi gravida in 
the high risk group of the study. 
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Table 2: Comparison of maternal age between the high risk group 
and normal group in the study population. 
S. 
No Parameter 
Normal 
group 
(n=50) 
High risk 
group 
(n=50) 
P value Statistical test 
1 Age in years 25.2 ± 3.4 25.6 ± 3.7 0.539 (NS) 
Unpaired ‘t’ 
test 
 
Data are expressed in mean ± SD. n= 50 in each group. P<0.05 is 
considered statistically significant and  unpaired ‘t’ test was used to find 
the statistical difference. Both the groups are comparable with respect to 
the maternal age in years. 
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Table 3: Comparison of maternal placental weight between the 
normal and high risk groups. 
S. 
No Parameter 
Normal 
group 
(n=50) 
High risk 
group 
(n=50) 
P value Statistical test 
1 
Placental 
weight in  
grams 
434.6 ± 
89.1 
387.8 ± 
84.3 0.008* 
Unpaired ‘t’ 
test 
 
Data are expressed in mean ± SD. n= 50 in each group. * indicates 
P<0.05 and  considered statistically significant. Hence high risk group 
has lower placental weight than the normal group patients. 
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Figure 3: Comparison of maternal placental weight between the 
normal and high risk groups. 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean with standard deviation. The length of the 
bar in the vertical bar diagram represents mean and error bars represent 
standard deviation. * indicates p value <0.05. Unpaired ‘t’ test was used 
to find the statistical significance. 
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Table 4: Comparison of maternal placental weight between the 
normal and high risk groups based on the parity. 
 
S. 
No Parameter 
Normal group (n=50) High risk group (n=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
P value 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
P 
value 
1 
Placental 
weight in  
grams 
432.6 
± 85.8 
436.3 ± 
93.5 
0.885 
(NS) 
392.8 ± 
77 
382.8 ± 
92.4 
0.679 
(NS) 
 
Data are expressed in mean ± SD. P<0.05 is considered statistically 
significant and  unpaired ‘t’ test was used to find the statistical 
difference. When based on parity there is no significant difference in the 
placental weight. 
The mean placental weight amongst primis, 23 cases was 432 and multis 
was 436.9 in the normal group. 
The mean placental weight amongst primis , 25 cases was 392.8 and 
multis was 382.8 in the high risk group. 
However placental weight of less than 300 gms is mainly noted in the 
high risk group. 
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Table 5: Comparison of size of the placenta in cm between the 
normal and high risk groups. 
 
S. 
No Parameter 
Normal 
group 
(n=50) 
High risk 
group 
(n=50) 
P value Statistical test 
1 Placental 
size in cm 16.2 ± 3.4 16.5 ± 4.6 0.712 (NS) 
Unpaired ‘t’ 
test 
 
Data are expressed in mean ± SD. n= 50 in each group. Both the groups 
are comparable in respect to the placental cord length. 
The mean placental size in the normal group is 16.2 cm and the mean 
placental size in the high risk group is 16.5 cm where there is no 
significant difference. 
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Table 6: Comparison of placental size in cm between the normal and 
high risk groups based on the parity. 
 
S
. 
N
o 
Parameter 
Normal group (n=50) High risk group (n=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
P 
value 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
P 
value 
1 
Placental 
size in 
cm 
15.7 ± 
3.8 
16.5 ± 
3.05 
0.38 
(NS) 
16.3 ± 
4.8 
16.9 ± 
4.3 
0.785 
(NS) 
 
Data are expressed in mean ± SD. P<0.05 is considered statistically 
significant and  unpaired ‘t’ test was used to find the statistical 
difference. 
There is no significant difference in the placental size when compared 
with the parity 
 
 
 47 
 
 
Table 7: Distribution of shape of placenta in normal and high risk 
group with respect to the parity. 
 
S. 
N
o 
Shape of 
the 
placenta 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Discoid 21(92%) 27 (100%) 
48 
(96%) 24 (96%) 
23 
(92%) 
47 
(94%) 
2 Bilobed 1 (4%) 0 (0%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 
3 Club 
shaped 1 (4%) 0 (0%) 1 (2%) 1 (4%) 2 (8%) 3 (6%) 
 
Data are expressed as absolute number with percentage. 
Number of cases with abnormal placental shape( club shaped and 
bilobed) was 4. 
There was only one case with abnormal placental shape in the normal 
group and whereas there are 3 cases in the high risk group with the 
abnormal shape.. 
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Table 8: Frequency distribution of grading of syncytial knots in the 
umbilical cord between the normal and high risk group in 
respect to the parity. 
 
S. 
N
o 
Grading of 
the 
syncytial 
knots 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Grade I 7 (30.4%) 
8 
(29.6%) 
15 
(30%) 3 (12%) 
3 
(12%) 
6 
(12%) 
2 Grade II 13 (56.5%) 17 (63%) 
30 
(60%) 11 (44%) 
13 
(52%) 
24 
(48%) 
3 Grade III 3 (13%) 2 (7.4%) 5 (10%) 11 (44%) 
9 
(36%) 
20 
(40%) 
 
Syncytial knots in high risk group: 
No of cases with syncytial knots grade I(0- 29%) were 3 cases in PIH, 1 
case in post dated, 1 case in preterm,1 in APH and nil in diabetes 
complicating pregnancy.( total- 6 cases) 
Syncytial knots gradeII(30-59%) were seen in 5 cases of PIH, 5 cases of 
GDM, 6 CASES of preterm, 4 cases of postdated, and 4 cases of 
APH.(total- 24 cases) 
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Syncitial knots grade III(60- 90%)  were seen in 1 case of PIH, 6 cases 
of GDM, 3 cases of PRETERM, 5 case of postdated and 5 cases of APH. 
(total-  20 cases). 
There was no case in high riskgroup with grade IV(90%) Syncitial knots. 
Syncytial knots in normal group: 
no of cases with grade I are 15 cases, grade II are 30 cases, grade III are 
5 cases and nil in grade IV.  
SYNCITIAL KNOTS OF GRADE III are more in the high risk 
group[40%] when compared to the normal group[10%]. 
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Table 9: Frequency distribution of grading of fibrosis in placenta 
between the normal and high risk group in respect to the parity. 
 
S. 
N
o 
Grading 
of 
placental 
fibrosis 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Grade O 16 (69.6%) 
20 
(74.1%) 
36 
(72%) 18 (72%) 
13 
(52%) 
31 
(62%) 
2 Grade I 4 (17.4%) 
3 
(11.1%) 
7 
(14%) 2 (8%) 
4 
(16%) 
6 
(12%) 
3 Grade II 3 (13%) 4 (14.8%) 
7 
(14%) 5 (20%) 
8 
(32%) 
13 
(26%) 
 
Fibrosis in high risk group: 
No of cases with no fibrosis are- 6 cases of PIH, 4 cases of  GDM, 8 
cases of preterm, 6 cases of postdated, 7 cases of APH totally 31 
cases(62%). 
Grade I fibrosis(0.3-3%) were seen in 1 case in PIH, 3 cases in GDM, 1 
case in preterm, 1 case in post dated and nil in APH. (Total- 6 
cases[12%]) 
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Grade II fibrosis (>3%)were seen in 2 cases of PIH, 4 cases of GDM, 1 
case of preterm, 3 cases of postdated, and 3 cases of APH( total 13 
cases[26%]). 
Fibrosis in the normal group: 
Grade 0 fibrosis in 36 cases[72%], grade I in 7 cases[14%] and grade III 
in 7 cases[14%]. 
Hence fibrosis of grade II is more in the high risk group[26%] when 
compared to the normal group[14%]. 
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Table 10: Frequency distribution of grading of fibrinoid necrosis in 
placenta between the normal and high risk group in 
respect to the parity. 
 
S. 
N
o 
Grading 
of 
placental 
fibrinoid 
necrosis 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Grade O 2 (8.7%) 3 (11.1%) 5 (10%) 0(0%) 0(0%) 0(0%) 
2 Grade I 17 (73.9%) 
18 
(66.6%) 
35 
(70%) 11 (44%) 
12 
(48%) 
23 
(46%) 
3 Grade II 4 (17.4%) 6 (22.3%) 
10 
(20%) 11 (44%) 
9 
(36%) 
20 
(40%) 
4 Grade III 0(0%) 0(0%) 0(0%) 3 (12%) 4 (16%) 
7 
(14%) 
Fibrinoid necrosis in the high risk group: 
Grade I(0-5%) were seen in 2 cases of PIH, 4 cases of  GDM, 7 cases of 
preterm, 5 cases of postdated, and 5 cases of APH. (total- 23 
cases[46%]). 
Grade II(5-10%) were seen in 6 cases of PIH, 3 cases of GDM, 3 cases 
of preterm, 4 cases of postdated, and 4 cases of APH. (Total – 20 
cases[40%]). 
Grade III(>10%) were seen in 2 cases of PIH, 3 cases of GDM, 1 case of 
preterm, 1 case of postterm and nil in APH, (total- 7 cases[14%]) 
Fibrinoid necrosis in the normal group: 
No fibrinoid necrosis in 5 cases, grade I in 35 cases, grade II in 10 cases, 
and nil cases in grade III. 
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Hence fibrinoid necrosis with grade II and grade III are more in high risk 
group than normal group.  
Syncitial knots 
 
FIBRINOID NECROSIS 
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Table 11: Comparison of placental calcification score between the 
normal and high risk groups. 
S. 
No Parameter 
Normal 
group 
(n=37) 
High risk 
group 
(n=50) 
P value Statistical test 
1 
placental 
calcification 
score 
3.27 ± 2.5 3.9 ± 5.7 0.485 (NS) 
Mann Whitney 
U test 
 
Data are expressed in mean ± SD. n= 37 in normal group (calcification 
was not seen in 13 subjects in normal group). 
Calcification was present in 6 cases of PIH, 9 cases of GDM, 8 cases of 
postdated, 6 cases of APH and only in 4 cases of preterm. Calcification 
was absent in 17 remaining cases in the high risk group. 
Whereas in normal group calcification was present in 37 cases and 
absent in 13 cases. 
Hence there is no significant difference in the calcification score 
between high risk and the normal group. 
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Table 12: Comparison of placental calcification score between the 
normal and high risk groups based on the parity. 
 
S. 
N
o 
Parameter 
Normal group (n=50) High risk group (n=50) 
Primi 
Gravida 
(n=18) 
Multi 
Gravida 
(n=19) 
P 
value 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
P 
value 
1 
placental 
calcification 
score 
3 ± 1.9 3.5 ± 3 0.827 (NS) 3.3 ± 3.9 4.5 ± 7.09 
0.964 
(NS) 
 
Data are expressed in mean ± SD. P<0.05 is considered statistically 
significant and  unpaired ‘t’ test was used to find the statistical difference 
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Table 13: Frequency distribution of placental calcification between 
the normal and high risk group in respect to the parity. 
S. No 
Calcification 
of placenta (% 
of area 
involved) 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 0 8 (35%) 12(44.4%) 20(40%) 
8 
(32%) 
8 
(32%) 
16 
(32%) 
2 1 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
3 2 7 (30.4%) 6 (22.2%) 
13 
(26%) 
5 
(20%) 
4 
(16%) 
9 
(18%) 
4 3 0 (0%) 0 (0%) 0 (0%) 2 (8%) 3 (12%) 
5 
(10%) 
5 4 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%) 1 (2%) 
6 5 8 (34.8%) 7 (25.9%) 
15 
(30%) 
7 
(28%) 
6 
(24%) 
13 
(26%) 
7 10 0 (0%) 2 (7.4%) 2 (4%) 1 (4%) 0 (0%) 1 (2%) 
8 15 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
9 18 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%) 1 (2%) 
10 20 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
11 30 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
 
This scoring says about the percentage of area affected by calcification. 
Distribution of placental calcification between the normal and high risk 
groups: 
Calcification High Risk group Normal group 
Absent 32% 40% 
Present 68% 60% 
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Table 14: Frequency distribution of infarction score in placenta 
between the normal and high risk group in respect to the 
parity. 
S. 
No 
Infarction 
in placenta  
(% of area 
involved) 
Normal group (N=50) High risk group (N=50) 
 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1  0 12 (52.2%) 
19 
(70.4%) 
31 
(62%) 3 (12%) 4 (16%) 7 (14%) 
2 2 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (4%) 2 (4%) 
3 3 2 (8.7%) 0 (0%) 2 (4%) 0 (0%) 5 (20%) 5 (10%) 
4 4 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
5 5 5 (21.7%) 6 (22.2%) 11 (22%) 15 (60%) 8 (32%) 
23 
(46%) 
6 8 0 (0%) 0 (0%) 0 (0%) 1 (4%) 0 (0%) 1 (2%) 
7 10 3 (13%) 1 (3.7%) 4 (8%) 1 (4%) 1 (4%) 2 (4%) 
8 13 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
9 15 1 (4.3%) 1 (3.7%) 2 (4%) 3 (12%) 2 (8%) 5 (10%) 
10 20 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (4%) 2 (4%) 
11 25 0 (0%) 0 (0%) 0 (0%) 0 (0%) 1 (4%) 1 (2%) 
 
This scoring says about the percentage of area affected by infarction. 
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INFARCTION IN HIGH RISK GROUP: 
Infarction was absent in 1 case of PIH, 1 case of GDM, 3 cases of 
postdated, 2 cases of APH. 
 INFARCTION  of <5% was present in 1 case of PIH, 5 cases of GDM, 
1 case of preterm, 1 case of APH. 
INFARCTION  of >5% was present in 8 cases of PIH, 4 cases of GDM, 
9 cases of preterm, 7 cases of postdated, and 7 cases of APH.  
INFARCTION IN THE NORMAL GROUP: 
Infarction was absent in 31 cases, <5% in 2 cases and >5% in 17 cases. 
Hence the percentage of area affected by infarction is more in the high 
risk group when compared to the normal group. 
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Table 15: Frequency distribution of Leukocyte infiltration in 
placenta between the normal and high risk group in 
respect to the parity. 
S. 
N
o 
Leukocyte 
infiltration 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Yes 2 (8.7%) 
8 
(29.6%) 
10 
(20%) 
12 
(48%) 
11 (44%) 
23 
(46%) 
2 No 
21 
(91.3%) 
19 
(70.4%) 
40 
(80%) 
13 
(52%) 
14 (56%) 
27 
(54%) 
 
LEUKOCYTE INFILTRATION was present in more no of cases in the 
high risk group(23 cases ) when compared to the normal group it was 
present only in 10 cases. 
 
 
0
5
10
15
20
25
30
35
40
45
Absent Present
P
e
rc
e
n
ta
g
e
Leucocytic infiltration
Leucocytic Infiltration in High Risk and Normal 
Group
High Risk Normal Group
 62 
 
Table 16: Frequency distribution of USG placental grading between 
the normal and high risk group in respect to the parity. 
S. 
No 
USG 
placental 
grade 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 Grade I 2 (8.7%) 3 (11.1%) 5 (10%) 3 (12%) 5 (20%) 8 (16%) 
2 Grade II 14 (60.9%) 
20 
(74.1%) 34 (68%) 15 (60%) 15 (56%) 
30 
(58%) 
3 Grade III 7 (30.4%) 4 (14.8%) 11 (22%) 6 (28%) 6 (24%) 12 (26%) 
 
PLACENTAL GRADING IN HIGH RISK GROUP: 
Grade I placenta was seen in 1 case of PIH, none in GDM, 3 
cases of preterm, 3 cases of postdated, and 1 case of APH.[total- 8 cases] 
Grade II placenta was seen in 6 cases of PIH, 7 cases of GDM, 7 
cases of preterm, 4 cases of postdated, 6 cases of APH. [total- 20 cases] 
Grade III placenta was seen in 2 cases of PIH, 4 cases of GDM, 
NONE in preterm, 3 cases in postdated, 3 cases in APH. [ total- 12 
cases] 
PLACENTAL GRADING IN NORMAL GROUP:   
Grade I placenta was seen in 5 cases, grade II  was seen in 34 
cases, grade III  was seen in 4 cases. 
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Table 17: Frequency distribution of mode of delivery between the 
normal and high risk group in respect to the parity 
S. 
No 
Mode of 
Delivery 
Normal group (N=50) High risk group (N=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
Total 
n (%) 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
Total 
n(%) 
1 
Labour 
Natural 
18 
(78.2%) 21 (77.7%) 39 (78%) 12 (48%) 14 (56%) 26 (52%) 
2 LSCS 
3 
(13.04%) 
4 (14.8%) 7 (14%) 10 (40%) 11 (44%) 21 (42%) 
3 
Vacuum 
assisted 
1 (4.3%) 0 (0%) 1 (2%) 0 (0%) 0 (0%) 0 (0%) 
4 
Forceps 
assisted 
1 (4.3%) 2 (7.4%) 3 (6%) 3 (12%) 0 (0%) 3 (6%) 
 
MODE OF DELIVERY IN HIGH RISK GROUP: 
No of labour natural was 26, LSCS  was 21 cases, forceps delivery was 3 
cases, 
 
MODE OF DELIVERY IN NORMAL GROUP: 
No of labour natural was 39 cases, lscs was 7 cases, 1 case of vaccum 
delivery, and 3 cases of outlet forceps delivery. 
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HENCE LABOUR NATURAL WAS MORE IN THE NORMAL 
GROUP, WHEREAS LSCS WAS MORE IN THE HIGH RISK 
GROUP COMPARED TO NORMAL GROUP. 
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Table 18: Comparison of placental thickness in USG between the 
normal and high risk groups. 
S. 
No Parameter 
Normal 
group 
(n=50) 
High risk 
group 
(n=50) 
P value Statistical test 
1 
Placental 
thickness in 
USG (cm) 
2.9 ± 0.44 3.09 ± 0.33 0.01* 
Mann 
Whitney U 
test 
 
Data are expressed in mean ± SD. * indicates p <0.05 and considered 
statistically significant 
The mean placental thickness is more in the high risk group when 
compared to the normal group. 
 
  
 67 
 
 
 
 
Table 19: Comparison of placental thickness in USG between the 
normal and high risk groups based on the parity. 
 
S. 
No Parameter 
Normal group (n=50) High risk group (n=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
P 
value 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
P 
value 
1 
Placental 
thickness 
in USG 
(cm) 
2.9 ± 0.5 2.9 ± 0.38 
0.72
9 
(NS) 
3.05 
±0.27 
3.13 ± 
0.38 
0.526 
(NS) 
 
Data are expressed in mean ± SD. P<0.05 is considered statistically 
significant and  unpaired ‘t’ test was used to find the statistical difference 
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The below picture show 2 dimensional measurement of placental 
thickness.  In the below picture the location of the placenta is lateral 
grannum grading stage 1. 
 
 
PLACENTAL THICKNESS MEASUREMENT. 
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Table 20: Comparison of neonatal outcomes between the normal 
and high risk groups based on parity. 
S. 
N
o 
Parameter 
Normal group (n=50) High risk group (n=50) 
Primi 
Gravida 
(n=23) 
Multi 
Gravida 
(n=27) 
P 
value 
Primi 
Gravida 
(n=25) 
Multi 
Gravida 
(n=25) 
P 
value 
1 
Weight of 
the baby (in 
Kg) 
2.8 ± 
0.32 2.7 ± 0.38 
0.159 
(NS) 2.4 ± 0.6 2.5 ± 0.61 
0.692 
(NS) 
2 
Weight of 
the baby 
overall 
(Kg) 
2.77 ± 0.36 2.5 ± 0.6 0.008* 
3 
Apgar Score 
< 7 0 (0%) 0(0%) 
<0.00
01* 
5 (20%) 3 (12%) 0.782 
(NS) ≥7 23 (100%) 
27 
(100%) 19 (76%) 19 (76%) 
Still birth 0 (0%) 0 (0%) 1 (4%) 3 (12%)  
 
Data are expressed in mean ± SD except apgar score wherein data are 
expressed as absolute numbers with percentage. * indicates p <0.05 and 
considered statistically significant. 
Low APGAR score is observed more in the babies of high risk group 
when compared to normal group. 
STILL BIRTH was seen in 4 cases of high risk group, whereas no still 
births in the normal group. 
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Table 21. Association of high risk factors with birth weight in the 
high risk population group 
 
S.No 
Type of birth 
weight 
Normal 
Group 
N=50 (%) 
High risk 
group 
N=50 (%) 
P value 
1 
<2500 grams 9 (18%) 23 (46%) 
0.0004* 
≥ 2500 grams 41 (72%) 27 (54%) 
 
Chi square test was used to test the statistical significance. * indicates 
p<0.05 and considered statistically significant. The odd’s ratio is 3.88 
(95% Confidence interval is 1.96 to 9.65) between the groups. Hence the 
odd’s of getting low birth weight baby is 3.8 times higher in high risk 
population than the normal group. 
LOW BIRTH WEIGHT was seen in more no of high risk cases when 
compared to that of normal group. 
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FETAL DISTRESS was observed more in the high risk group when 
compared to the normal group. 
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DISCUSSION 
PLACENTAL ULTRASONOGRAPHY 
The grading and placental thickness was compared with study done by 
Tewari k et al(1995 and 1997) 
Placental grading and mean placental thickness- comparison of present 
study with other published studies 
Tewari k et al. 1995 
Grading MPT(mm) 
I 49.7+5.4 
II 40.0+3.4 
III 34.2+3.6 
 
Tewari k et al.1997 
GA MPT(mm) 
28-32 51.86+5.7 
32-36 43.70+4.5 
>36 37.40+5.5 
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Present study 2017 
Grade MPT(mm)  
 High risk Normal 
0 36 - 
I 29 24.4 
II 30.7 29 
III 32.2 28 
 
The mean placental thickness in grade III correlates with the study done 
by Tewari k et al.(1995). There was no correlation found between 
placental thickness and adverse fetal outcome.  
Placental grading was correlated with the fetal outcome. In the high risk 
group, In placenta with grade I there were 8 cases out of which 1 case 
had fetal distress and 1 case had still birth. 
In 29 cases with grade II, 5 cases had low APGAR score, 5 cases had 
fetal distress and there were 2 cases of still birth. 
In 13 cases with grade III, only 2 cases had fetal distress and 2 cases low 
APGAR. There was no still birth. Cases with grade III placentas 
comparatively had low adverse fetal outcomes. 
In the normal group, 5 cases of grade I placenta, 34 cases of grade II 
placenta and 11 cases of grade III had normal fetal outcome. 
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HISTOPATHOLOGICAL STUDY OF PLACENTA 
MACROSCOPIC STUDY OF PLACENTA: 
Placental weight <300 gms- comparison of present study with other 
published studies. 
AUTHOR HIGH RISK NORMAL 
Neerja et al. 1999 22% 0% 
Banadanadas et al.1996 45.7% 0% 
Anjali R et al 1985 23% 0% 
Rathna R et al 2002 4% 0% 
Present study 12% 6% 
 
Only 3 cases in the normal group had placental weight of <300 gms. In 
high risk group, 6 cases had weight <300 gms. 
1 case in the high risk group with placental weight <300 gms had fetal 
distress. 
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PLACENTAL SIZE OF >20cm- comparison of present study with other 
published studies 
AUTHORS HIGH RISK NORMAL 
Bandanadas et al 
1996 5% 0% 
Rathna R et al 2002 16% 4% 
Present study 14% 6% 
There was significant correlation between placental size and fetal 
outcome. 
Here present study correlates with the study done by rathna R et al. 
 
SYNCITIAL KNOTS OF>30%- COMPARISON OF PRESENT 
STUDY WITH OTHER STUDIES. 
Authors High risk Normal 
Avasthik et al 1991 40.8% 0% 
Twearik et al 1997 74.5% 16.5% 
neerja et al 1999 33% 3% 
Rathna R et al 2002 40% 8% 
Present study 88% 70% 
There is a significant increase in the syncytial knotting in the high risk 
group of pregnancies. 
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FIBRINOID NECROSIS OF >5%- COMPARISON OF PRESENT 
STUDY WITH OTHER PUBLISHED STUDIES 
Authors High risk Normal 
Avasthik et al 1991 20 0 
Twearik et al 1997 47 0 
neerja et al 1999 32 0 
Rathna R et al 2002 50 20 
Present study 54 20 
 
Present study correlates with study done by rathna R et al. fibrinoid 
necrosis of higher grades II and III was found to be in PIH cases 
followed by GDM, and POSTTERM. 
FIBROSIS OF >3%- COMPARISON OF PRESENT STUDY 
WITH OTHER PUBLISHED STUDIES 
Authors High risk Normal 
Avasthik et al 1991 30% 0 
Twearik et al 1997 59.5% 0 
Neerja et al 1999 32% 0 
Rathna R et al 2002 38% 28% 
Present study 26% 14% 
 
Fibrosis of grade II is more in the high risk group when compared to the 
normal group. This present study is comparable with the study done by 
rathna r et al. 
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LEUKOCYTIC INFILTRATION- COMPARISON OF PRESENT 
STUDY WITH OTHER PUBLISHED STUDIES 
Authors High risk  normal  
 present absent present Absent 
avasthi k et 
al 1991 20.6% 79.9% 0% 100% 
Neerja et al 
1999 30% 70% 0% 100% 
Rathna R et 
al 2002 48% 52% 20% 80% 
present 
study 46% 54% 20% 80% 
Present is found to be comparable with study done by rathna r et al. 
 
 
INFARCTION OF >5%- COMPARISON OF PRESENT STUDY 
WITH OTHER PUBLISHED STUDIES 
Authors High risk  normal  
 present absent present Absent 
avasthi k et 
al 1991 25% 75% 8% 92% 
Rathna R et 
al 2002 66% 17% 12% 78% 
present 
study 86% 14% 38% 62% 
Present study is comparable with that of study done by rathna r et al. 
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CALCIFICATION- COMPARISON OF PRESENT STUDY WITH 
OTHER PUBLISHED STUDIES 
Authors High risk  normal  
 present absent present Absent 
avasthi 
k et al 
1991 
25% 75% 8% 92% 
Rathna 
R et al 
2002 
64% 36% 56% 44% 
present 
study 
68% 32% 60% 40% 
 
Present study is comparable with that of study done by rathna r et al. 
MODE OF DELIVERY- COMPARISON OF PRESENT STUDY 
WITH OTHER PUBLISHED STUDIES 
Authors VAGINAL  LSCS  
 High risk normal High risk Normal 
neerja et al 
1999 44% 70% 56% 30% 
Rathna R et 
al 2002 52% 64% 48% 16% 
present 
study 58% 86% 42% 14% 
Present study is comparable with that of study done by rathna r et al 
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FETAL OUTCOME- COMPARISON OF PRESENT STUDY 
WITH OTHER PUBLISHED STUDIES 
Fetal 
outcome 
Rathna r et 
al 2002  
Present 
study  
 High risk Normal High risk Normal 
Fetal 
distress 32% 4% 18% 8% 
LOW 
APGAR 24% 0% 14% 0% 
Still birth 10% 0% 8% 0% 
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CORRELATION OF HISTOLOGIC FINDINGS WITH FETAL 
OUTCOME 
Histological 
features 
Fetal distress 
18% 
Low APGAR 
14% 
STILL BIRTH 
8% 
Syncitial knots    
I(0-29%) 16% 16% 0% 
II(20-59%) 12.5% 8.3%% 4% 
III(60-89%) 15% 5% 6% 
IV(>90%) Nil Nil Nil 
Fibrinoid necrosis    
I(0-5%) 17% 4% 4% 
II(5-10%) 10% 20% 10% 
III(>10%) 42% 0% 14% 
Fibrosis    
Absent    
I(0.3-3%) 16% 16% Nil 
II(>3%) 7% 15% 7% 
Infarction    
(0-5%) 18% 5% NIL 
(6-10%) NIL 100% NIL 
(>10%) 11% 22% 44% 
Calcification     
Absent 12% NIL 6% 
Present 17% 20% 8% 
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HENCE ADVERSE FETAL OUTCOMES ARE ASSOCIATED WITH 
INCREASING GRADES OF SYNCITIAL KNOTS, FIBROSIS, 
FIBRINOID NECROSIS AND INFARCTION. ALSO WHEN THE 
LEUKOCYTE INFITRATIONAND CALCIFICATION ARE 
PRESENT THERE IS INCREASED PERCENTAGE OF FETEL 
DISTRESS, LOW APGAR AND STILL BIRTH. 
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SUMMARY 
       Infants with growth restriction have smaller placentas relative to 
infants with normal birth weight of similar gestational age. As growth 
restriction continues, the ratio of birth weight to placental weight is 
reduced. Progressively more placental mass is required to maintain the 
fetus. 
            Examination of the placenta gives information which will lead to 
a clear understanding of the origin of the abnormal outcome and is a 
valuable tool in predicting the outcome of future pregnancies and their 
management. 
           Sonographic placental changes in terms of thickness with 
advanced maturational grades correspond to histological features 
suggestive of villous aging, uteroplacental ischemia and hampered fetal 
villous perfusion, thus adversely affecting the growth of the fetus. 
Ultrasonographic placental grading gives an idea about the fetal 
maturity.  
         There is an exaggerated response of placenta to various disorders 
complicating pregnancies  and the degree of pathological abnormalities 
may have an impact on the fetal growth.  
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           The present study shows a significant correlation between the 
histological abnormalities of placenta and fetal outcome. But the 
pathologic changes in the placenta are not specific to a particular 
disorder and a variety of disorders may have similar changes          
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CONCLUSION 
Healthy baby and healthy mother is the goal of every obstetrician.  The 
study is a humble endeavor to assess the propable link of morphological 
and histopathological changes in placenta to fetal outcome and thereby 
pave way for better fetal outcome.  Many, such studies are done all over 
the world and days may not be far off when a definite link is proved. 
 Examination of placenta with warning signals for neonatal 
outcome revealed within few days, in a tertiary care hospital may alert 
the obstetrician as well as the neonatalogist to keep such babies under 
careful monitoring in NICU. 
 
        The  ultrasonograhic and histopathological study of placenta may 
suggest the possible pathogenesis due to decreased or compromised 
uteroplacental function. Early detection, timely intervention and good 
antenatal care of high risk patients may prevent the adverse fetal 
outcome and thus reduce the incidence of fetal growth restriction. 
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PROFORMA 
Name:                       
Age:              
IP No.: 
Place:                       Occupation: 
LMP:                         EDD: 
Diagnosis: 
Menstrual history: 
 
GENERAL EXAMINATION:          
Height:    cm.                    
 Weight:    kg. 
BP:            mm of Hg.       Pulse rate: 
Temp:                                 Pallor: 
Pedal edema:                   
CLINICAL EXAMINATION: 
CVS: 
RS: 
P/A: 
Fundal height: 
 
INVESTIGATIONS: 
ROUTINE: 
Hb                          : 
PLATELET          : 
BLOOD SUGAR : 
UREA                    : 
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CREATININE      : 
LFT                        : 
PPTCT                   : 
Blood group and Type: 
URINE: Albumin:        Sugar:        Deposits: 
 
SPECIFIC (If any) : 
 
 
USG on 
FETAL BIOMETRY: 
BPD 
FL 
AC 
HC 
HC/AC 
 
BIOPHYSICAL PROFILE: 
Breathing movements: 
Movements: 
Tone: 
Reactive Heart rate: 
EFW       gms. 
AFI          cm 
 IMPRESSION: 
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ULTRASONOGRAPHIC STUDY OF PLACENTA: 
Grading:                                
 Thickness: 
 
 
MACROSCOPIC STUDY OF PLACENTA: 
Size:              diameter in cms 
Shape: 
Weight:         gms. 
Colour of the membranes: 
No. of cord vessels: 
Cord length:           
 
HISTOPATHOLOGICAL EXAMINATION OF PLACENTA: 
Infarction:               % 
Calcification:          % 
Syncitial knots: Grade 
Fibrosis: Grade 
Fibrinoid necrosis: Grade 
Leucocytic infiltration: + / - 
 
MODE OF DELIVERY: 
INDICATION FOR INTERVENTION: 
Baby notes: 
Sex: f/m   
 Weight:    kg. 
Live birth/ still birth: 
 APGAR:    1min     5min  
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Signs of fetal distress: 
 NICU admission: yes/ no 
Reason for admission: 
Outcome: 
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PATIENT CONSENT FORM 
 
Study Detail: A Study on “ANTENATAL ULTRASOUND AND 
POSTPARTUM HISTOPATHOLOGICAL STUDY OF PLACENTA IN 
HIGH RISK PREGNANCIES AND ITS CORRELATION WITH FETAL 
OUTCOME” 
 
Study Centre: Department of Obstetrics & Gynaecology, Thanjavur 
medical college, Thanjavur. 
I confirm that I have read and understood the information Sheet 
for the above study. I have had the opportunity to ask questions and all 
my questions and doubt have been answered to my complete satisfaction. 
I understand that my participation in the study is voluntary and 
that i am free to withdraw at an time, without giving any reason, without 
my legal rights being affected. 
I understand that the Clinical study personnel, the Ethics 
Committee and the Regulatory Authorities will not need my permission 
to look at my health records both in respect to the current study and any 
further research that may be conducted in relation to it, even if i 
withdraw from the study. I agree to this access. However, I Understand 
that my identity will not be revealed in any information released to third 
parties or published, unless as required under the law. I agree not to 
restrict the use of any data or results that arise from this study. 
I agree to take part in the above study and to comply with the 
instructions given during the study and to faithfully co-operate with the 
study team, and to immediately inform the study if I suffer from any 
deterioration in my health of well being or any unexpected or unusual 
symptoms. 
I hereby give permission to undergo completed clinical 
examination and diagnostic tests including haematological, biochemical, 
radiological tests. 
I hereby consent to participate in this study. 
Signature/Thumb impression:.......................   Place                  Date 
of the patient 
Patient’s Name, Address & Ph.No:..................................................... 
Name of the Investigation:...................................... 
Signature of the Investigator: ......................   Place...................Date 
Institution : ................................................................ 
Signature of the Relative/Gardian...............................  
  
 
 
KEY TO MASTER CHART 
 
 
 
 
GHT: gestational hypertension 
GDM: gestational diabetes mellitus 
APH: antepartum haemorrhage 
D:       discoid 
B:        bilobed 
C:        club shaped 
Lscs:   lower segment caesarean section 
CPD : cephalopelvic disproportion 
MSAF: meconium stained amniotic fluid 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
S.No Name Age IP No Parity High risk factor
placental 
weight g
placental 
size in cm
shape of 
placenta
synctitial 
knots fibrosis
fibrinoid 
necrosis calcification infarction
leuckocyte 
infiltration
1 Jacquelin sandhanmary 28 468201 Multi GHT 350 24 D III II II 0 0 +
2 Abirami 20 469499 Primi GHT 450 15 D II 0 III 5 15 +
3 Suseela 24 469546 Primi GHT 250 15 D I 0 II 5 5 +
4 Kokila 19 469859 Primi GHT 320 18 D II 0 II 5 8 +
5 Rekha 24 465239 Multi GHT 340 18 D I 0 I 0 3 +
6 Nivetha 24 465150 Primi GHT 600 20 D II 0 III 0 5 +
7 Arokya ramya 22 462015 Primi GHT 400 25 D I II I 5 5 -
8 Malathi 28 468146 Multi GHT 300 14 D II 0 II 5 5 -
9 Kala 30 479168 Multi GHT 280 18 D II I II 2 15 +
10 Valarmathi 29 470684 Primi GHT 600 24 D III 0 II 5 5 +
11 Libiya 29 479499 Multi GDM 230 20 C III II III 2 5 -
12 Jeyanthi 32 479522 Multi GDM 350 22 D II II I 30 3 -
13 Vijaya 24 480612 Primi GDM 500 24 D III 0 II 0 5 -
14 Kavitha 30 481718 Multi GDM 450 16 D II I III 1 3 -
15 Selvi 27 484702 Multi GDM 400 20 D II II I 5 3 -
16 Anandharuby 29 489245 Primi GDM 380 15 D III 0 I 2 0 -
17 Mallika 25 480486 Multi GDM 350 14 D II 0 I 15 5 +
18 Vanathi 29 487124 Primi GDM 500 18 D III I II 2 2 +
19 Kauveri 31 492196 Multi GDM 420 20 C III I II 2 2 -
20 Manimala 26 487418 Primi GDM 450 22 D II II III 18 5 -
21 Sumathi 19 474016 Primi preterm 450 9 D II I I 10 5 +
22 Valli 28 474289 Primi preterm 390 10 D I 0 I 5 5 -
23 Uma 26 481268 Multi preterm 300 10 D III II III 2 20 +
24 Banumathy 21 480855 Multi preterm 250 8 D II 0 I 0 5 -
25 Minnalkodi 25 480888 Primi preterm 350 12 D III 0 II 0 20 +
26 Shanthi 24 480802 Multi preterm 300 9 D II 0 I 0 5 -
27 Sasikala 31 483701 Primi preterm 400 15 D II 0 I 0 5 -
28 Kalaivani 22 492614 Primi preterm 300 10 D III 0 II 2 5 -
29 Keerthika 20 484321 Primi preterm 280 12 D II 0 I 0 5 -
30 Amudha 25 481602 Multi preterm 250 14 D II 0 I 0 3 +
31 Manimegalai 32 477664 Multi post dated 650 18 D I 0 I 0 0 -
32 Kowsalya 28 476999 Primi post dated 400 6 D II 0 II 0 0 -
33 Sudha 24 482142 Primi post dated 350 15 D III II I 3 5 +
34 Selvi 27 478387 Multi post dated 450 15 D III II I 0 0 +
S.No Name Age IP No Parity High risk factor
placental 
weight g
placental 
size in cm
shape of 
placenta
synctitial 
knots fibrosis
fibrinoid 
necrosis calcification infarction
leuckocyte 
infiltration
35 Vijayalakshmi 18 481245 Multi post dated 400 16 D III II II 3 15 -
36 Gunasundari 19 480657 Multi post dated 400 15 D II I II 5 13 -
37 Mahalakshmi 26 478557 Multi post dated 550 25 D III 0 III 20 25 +
38 Vennila 29 477286 Primi post dated 500 20 C II 0 II 4 15 +
39 Vimala 24 488635 Primi post dated 450 15 D III 0 I 3 5 +
40 Suseela 28 484574 Multi post dated 550 20 D II 0 I 5 5 -
41 Thilagavathy 30 499053 Multi APH 550 20 D I 0 II 5 5 -
42 Vimala 24 480699 Multi APH 350 15 D II 0 I 0 5 -
43 Rajakumari 22 480601 Multi APH 450 20 D III 0 II 3 10 +
44 Kala 28 488630 Primi APH 500 18 D II II I 0 0 -
45 Sevanthiamal 26 483046 Primi APH 450 18 D III 0 I 0 5 -
46 Renuka 26 488055 Primi APH 500 14 D III 0 II 2 15 +
47 Annalakshmi 29 483046 Multi APH 400 12 D III II II 3 4 +
48 Chitra 28 481284 Primi APH 450 18 D III 0 II 2 5 -
49 Usharani 24 479267 Primi APH 400 20 D II II I 5 10 -
50 Priya 20 481450 Multi APH 450 14 D II 0 I 5 0 +
51 Gomathi 24 499692 Primi nil 450 24 D III II II 0 15 -
52 Gnanamani 22 475004 Primi nil 400 8 D II 0 II 0 0 -
53 Sumathi 30 480527 Primi nil 500 13 D II 0 I nil 3 +
54 Tamilselvi 27 485624 Primi nil 500 13 D I 0 I 2 0 -
55 Visalakshi 29 481234 Primi nil 450 12 D I 0 I 5 0 -
56 Rajeshwari 26 476125 Multi nil 500 14 D II I I 2 0 -
57 Senthamilselvi 24 481298 Multi nil 500 15 D I 0 I 5 0 +
58 Palaniyammal 19 470654 Multi nil 400 15 D II 0 I nil 0 -
59 Muthamilselvi 24 476134 Primi nil 450 15 B II 0 I 2 0 -
60 Pushpalatha 29 480679 Primi nil 450 18 D I 0 I nil 0 -
61 Nirmala 27 480888 Multi nil 500 20 D I 0 I nil 0 -
62 Radha 24 471965 Multi nil 500 19 D II 0 I nil 0 -
63 Nagammal 25 478564 Primi nil 500 9 D II II II 5 0 -
64 Sumathi 28 474421 Multi nil 450 18 D II II I nil 5 -
65 Selvi 23 473428 Multi nil 550 14 D I 0 0 5 10 +
66 Sundari 24 484123 Primi nil 550 18 D II 0 I 5 0 -
67 Rajalakshmi 23 476942 Multi nil 600 15 D II 0 I 2 5 +
68 Kala 24 476134 Multi nil 500 14 D III I II 5 0 -
69 Uma 28 489256 Primi nil 400 18 D II 0 I 5 10 -
S.No Name Age IP No Parity High risk factor
placental 
weight g
placental 
size in cm
shape of 
placenta
synctitial 
knots fibrosis
fibrinoid 
necrosis calcification infarction
leuckocyte 
infiltration
70 Revathy 34 490154 Primi nil 450 18 D II 0 I nil 0 -
71 Anjammal 29 482453 Primi nil 550 16 D I I I 2 5 -
72 Thamaraiselvi 27 489269 Primi nil 450 12 D II 0 I 5 0 -
73 Parvathi 26 478405 Primi nil 400 20 D II 0 0 2 0 -
74 Usha 24 481297 Multi nil 550 14 D I 0 I 0 0 +
75 Vijayalakshmi 25 473468 Multi nil 450 16 D II 0 I 5 0 -
76 Chitra 23 474281 Multi nil 450 14 D III II II 0 15 -
77 Nandhini 21 477419 Multi nil 400 12 D II 0 0 nil 0 -
78 Pavithra 22 482352 Primi nil 500 18 D II 0 I 2 3 -
79 Suganya 20 477545 Multi nil 500 20 D II 0 I 5 0 -
80 Kokilam 18 477781 Multi nil 450 16 D I 0 I 2 5 -
81 Malathy 24 470166 Primi nil 500 14 D II I I 5 0 -
82 Parimala 22 482432 Multi nil 500 18 D II 0 II nil 0 +
83 Angelin 21 484331 Multi nil 450 20 D I 0 I 2 0 -
84 Kasthuri 23 478631 Multi nil 380 22 D II 0 I nil 0 -
85 Udhaya 20 477664 Primi nil 250 16 D III 0 I nil 5 -
86 Abirami 28 476669 Primi nil 260 16 D II 0 I 2 0 -
87 Abinaya 27 482142 Multi nil 320 18 D II 0 II 5 0 +
88 Vidhya 29 478387 Primi nil 400 20 D I II 0 5 10 -
89 Sathya 28 482115 Multi nil 450 24 D I II I 10 0 -
90 Suseela 28 471657 Multi nil 520 12 D I I II nil 0 -
91 Jayakodi 26 478587 Primi nil 500 14 D II 0 I 2 5 -
92 Valli 27 477286 Multi nil 380 16 D II 0 I 2 0 -
93 Sandhya 31 488635 Multi nil 280 20 D II 0 I 0 5 +
94 Saranya 30 484574 Primi nil 290 20 C III I I 5 5 +
95 Nithya 25 483085 Multi nil 300 18 D II 0 II 0 5 -
96 Kanagam 28 499053 Primi nil 450 12 D I 0 I 0 10 -
97 Kavitha 24 480699 Multi nil 400 14 D II 0 I 2 0 -
98 Kalpana 29 480601 Multi nil 220 14 D II II 0 5 0 -
99 Parvathi 20 488921 Multi nil 280 16 D II 0 I 10 5 +
100 Menaka 22 488630 Primi nil 300 18 D I I II nil 5 -
S.No Name
1 Jacquelin sandhanmary
2 Abirami
3 Suseela
4 Kokila
5 Rekha
6 Nivetha
7 Arokya ramya
8 Malathi
9 Kala
10 Valarmathi
11 Libiya
12 Jeyanthi
13 Vijaya
14 Kavitha
15 Selvi
16 Anandharuby
17 Mallika
18 Vanathi
19 Kauveri
20 Manimala
21 Sumathi
22 Valli
23 Uma
24 Banumathy
25 Minnalkodi
26 Shanthi
27 Sasikala
28 Kalaivani
29 Keerthika
30 Amudha
31 Manimegalai
32 Kowsalya
33 Sudha
34 Selvi
USG 
placental 
grade
Placental 
thickness 
mm
Mode of 
delivery
Indication for operative 
procedures
Baby 
weight 
kg
apgar 
score
II 3.4 LSCS Previous LSCS/CPD 3.1 8
II 3 Vaginal 2.6 9
II 3.5 Vaginal 2.5 3
II 3 Forceps Fetal distress 2.5 5
II 3.5 LSCS Fetal distress 2.2 8
II 3.8 LSCS Failed induction 3.5 8
III 3 Vaginal 2.8 9
III 2.6 Vaginal 2.75 8
I 3 Vaginal 1.6 0
III 3.2 LSCS Failed induction 3.25 8
III 4.2 LSCS Fetal distress 3.98 8
II 3.2 Vaginal 3 9
II 3.1 Vaginal 2.5 8
II 2.8 Vaginal 2.4 7
II 3.4 LSCS Previous LSCS/CPD in labour 2.25 8
III 3 Forceps Failed maternal effects 3 8
II 3 LSCS Fetal distress 3.1 9
II 2.8 Vaginal 2.7 8
III 3.8 Vaginal 2.4 8
II 3 LSCS MSAF/Fetal distress 3.5 9
II 3.1 Vaginal 1.9 8
II 2.8 Vaginal 1.8 9
II 3 Vaginal 1.8 0
II 3 Vaginal 1.5 8
II 3 Vaginal 2 0
I 3.6 Vaginal 1.75 8
I 3.4 Vaginal 2.4 9
II 3.2 LSCS Fetal distress 1.9 8
II 3 Vaginal 1.7 8
I 3 Vaginal 1.8 8
II 2.8 LSCS Failed induction 3 9
I 2.4 Vaginal 2.1 9
III 3 Vaginal 1.2 8
I 3.4 Vaginal 2.75 9
S.No Name
35 Vijayalakshmi
36 Gunasundari
37 Mahalakshmi
38 Vennila
39 Vimala
40 Suseela
41 Thilagavathy
42 Vimala
43 Rajakumari
44 Kala
45 Sevanthiamal
46 Renuka
47 Annalakshmi
48 Chitra
49 Usharani
50 Priya
51 Gomathi
52 Gnanamani
53 Sumathi
54 Tamilselvi
55 Visalakshi
56 Rajeshwari
57 Senthamilselvi
58 Palaniyammal
59 Muthamilselvi
60 Pushpalatha
61 Nirmala
62 Radha
63 Nagammal
64 Sumathi
65 Selvi
66 Sundari
67 Rajalakshmi
68 Kala
69 Uma
USG 
placental 
grade
Placental 
thickness 
mm
Mode of 
delivery
Indication for operative 
procedures
Baby 
weight 
kg
apgar 
score
II 3.2 Vaginal 2.75 8
III 3 LSCS CPD 2.1 4
II 2.8 LSCS Fetal distress 3.25 0
II 3.4 Forceps Failed maternal effects 2.6 9
I 3 LSCS Fetal distress 3.5 8
III 3 LSCS Failed induction 3.4 8
II 2.4 LSCS Placenta previa with bleeding 2.75 8
I 3.2 LSCS Previous LSCS/Placenta previa in labour2 8
II 3 Vaginal 2.4 2
III 2.8 LSCS Abruption/Fetal distress 3 8
III 3 LSCS Abruption/Unfavourable cervix 2.6 2
III 3 LSCS Placenta previa with bleeding 2.3 6
II 2.8 Vaginal 2.75 5
II 3 LSCS Previous LSCS/Placenta previa in labour2.2 8
II 2.8 LSCS Placenta increta 1.8 5
III 3.2 Vaginal 2.8 9
III 4.5 Vaginal Prolonged 2nd stage 2.6 9
III 2.6 Vaginal 2.9 9
II 2.8 Vaginal 3 8
III 2.4 Vaginal 3 8
III 2.4 Vaginal 2.4 9
I 2.5 Vaginal 2.8 7
II 3 Vaginal 2.5 8
III 2.5 LSCS Severe Oligohydramnios 2.5 8
II 2.5 Vaginal 2.7 9
II 3 Vaginal 3 7
II 3.2 Vaginal 2.8 8
II 3.2 Forceps Fetal distress 3 8
III 3.5 Vaginal 2.2 9
II 4 LSCS CPD 2.6 9
II 3 Vaginal 2.9 8
II 3.4 Vaginal 3 8
III 3.6 Vaginal 3.25 9
II 2.8 Vaginal 3.5 8
II 3.6 Vaginal 2.8 8
S.No Name
70 Revathy
71 Anjammal
72 Thamaraiselvi
73 Parvathi
74 Usha
75 Vijayalakshmi
76 Chitra
77 Nandhini
78 Pavithra
79 Suganya
80 Kokilam
81 Malathy
82 Parimala
83 Angelin
84 Kasthuri
85 Udhaya
86 Abirami
87 Abinaya
88 Vidhya
89 Sathya
90 Suseela
91 Jayakodi
92 Valli
93 Sandhya
94 Saranya
95 Nithya
96 Kanagam
97 Kavitha
98 Kalpana
99 Parvathi
100 Menaka
USG 
placental 
grade
Placental 
thickness 
mm
Mode of 
delivery
Indication for operative 
procedures
Baby 
weight 
kg
apgar 
score
II 3 Vaginal 2.6 9
II 2.8 Vaginal 2.5 9
II 2.4 LSCS CPD 3.4 8
II 3 Vaginal 3.2 9
II 3.2 Vaginal 2.8 7
II 2.6 Forceps Fetal distress 2.1 8
II 2.8 Vaginal 2.9 8
II 2.4 Vaginal 3.4 8
II 2.4 Vaccum Prolonged 2nd stage 3.2 9
II 2.5 LSCS Non reactive CTG 2.7 7
III 3 Vaginal 3.1 8
I 2.5 Vaginal 2.8 8
II 2.8 Vaginal 2.5 9
II 3.2 Vaginal 2.5 9
II 3.3 Vaginal 2.6 9
III 3.4 Forceps Fetal distress 3 8
II 2.8 LSCS CPD 2.9 8
II 3 Vaginal 2.25 8
II 3.2 Vaginal 2.8 9
I 3.3 LSCS Previous LSCS/CPD in labour 2.5 8
II 2.5 Vaginal 2.4 9
II 2.6 Vaginal 3.25 9
III 2.8 Vaginal 3.1 9
II 3 Vaginal 2.2 9
III 3 Vaginal 2.8 9
I 3.2 Vaginal 3.2 8
II 3 LSCS Fetal distress 3.4 9
II 2.5 Vaginal 2.6 7
II 2.4 Vaginal 2.1 8
II 2.8 Vaginal 2.4 8
I 2.6 Vaginal 2.25 9
